Published February 3, 2017
| Version v1
Journal article
Open
An Italian cost-effectiveness analysis of paclitaxel albumin (nab®-paclitaxel) + gemcitabine vs gemcibatine alone for metastatic pancreatic cancer patients: The APICE study
Description
n/a
Files
fulltext.pdf
Files
(36.6 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:4bce5ad4cf9f79f8195892d9cfa9a1b6
|
36.6 kB | Preview Download |